Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants.
Li T, Xue W, Zheng Q, Song S, Yang C, Xiong H, Zhang S, Hong M, Zhang Y, Yu H, Zhang Y, Sun H, Huang Y, Deng T, Chi X, Li J, Wang S, Zhou L, Chen T, Wang Y, Cheng T, Zhang T, Yuan Q, Zhao Q, Zhang J, McLellan JS, Zhou ZH, Zhang Z, Li S, Gu Y, Xia N.
Li T, et al. Among authors: zhou zh, zhou l.
Nat Commun. 2021 Sep 27;12(1):5652. doi: 10.1038/s41467-021-25997-3.
Nat Commun. 2021.
PMID: 34580306
Free PMC article.